Dyslipidemia, Obesity and Metabolic Dysfunction-Associated Fatty Liver Disease: From Roots to Management
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Endocrinology".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 62
Special Issue Editors
2. Department of Basic and Clinical Pharmacology with Toxicology, Faculty of Medicine, University of Rijeka, Braće Branchetta 20, 51000 Rijeka, Croatia
Interests: clinical pharmacology; diabetes; evidence-based medicine; metabolic syndrome; obesity
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Patients with metabolic dysfunction-associated fatty liver disease (MAFLD), often considered the hepatic manifestation of metabolic syndrome (MetS), represent a population frequently suffering from atherogenic dyslipidemia and posing a significantly increased cardiovascular risk. Since dyslipidemia, obesity/MetS and MAFLD share etiopathogenesis roots and are all major drivers of atherosclerotic cardiovascular disease, impaired quality of life and reduced life span, their early detection and comprehensive multidisciplinary management are warranted.
Considering their constantly growing prevalence and associated global public health concerns, we are collating this Special Issue titled “Dyslipidemia, Obesity and Metabolic Dysfunction-Associated Fatty Liver Disease: From Roots to Management”.
For this Special Issue, we aim to publish outstanding contributions in the key fields covered by the journal, which will make a great contribution to the community. Thus, we believe that Medicina is an excellent platform to support such an overview on the current evidence and insights regarding dyslipidemia, obesity/metabolic syndrome and MAFLD.
We hope that our Special Issue will draw the attention of the readers, scientists and clinicians in general.
Dr. Andrej Belančić
Prof. Dr. Željko Krznarić
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- adipose tissue
- dyslipidemia
- metabolic dysfunction-associated fatty liver disease
- metabolic syndrome
- obesity
